
1. Moving the Markets
Markets on Tuesday flashed their first signs of stabilization as the Dow shot up more than 200 points following a sullied performance last week after the U.K. exit. I am sure equity indexes were oversold during the past couple of days, but it remains to be seen whether this is just hopeful bargain hunting combined with quarter-end window dressing or the resumption of the previous bull market. Global economic weakness and over-indebtedness are still lurking in the background and could put an end to this apparent volume-less dead cat bounce in a hurry.
Stocks that moved higher today include digital marketing company ReachLocal (RLOC) on its merger with Gannett (GCI), Cigna (CI) and SolarCity (SCTY) as Elon Musk’s solar systems maker formed a special committee to evaluate Tesla’s (TSLA) takeover bid. The panel’s creation is seeking to avoid any potential conflicts of interest between the two companies.
In pharma news, we heard today that U.S. pharmaceutical giant Pfizer (PFE) plans to invest roughly $350 million to develop a biotechnology center in China, which could increase the company’s footprint in the world’s second-largest pharmaceutical market. The new facility, which will be their first in China, will be built in Hangzhou and will provide both biologic treatments (medications made in microorganisms, plants or animal cells) for patients in China and worldwide.





